Use of monitoring levels of soluble forms of cytokeratin 18 in the urine of patients with superficial bladder cancer following intravesical Ad-IFNα/Syn3 treatment in a phase l study
Benedict, W F, Fisher, M, Zhang, X-Q, Yang, Z, Munsell, M F, Dinney, C N PVolume:
21
Language:
english
Journal:
Cancer Gene Therapy
DOI:
10.1038/cgt.2014.1
Date:
March, 2014
File:
PDF, 225 KB
english, 2014